{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:09Z","timestamp":1786980489232,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Green Cross Coporation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10067-019-04857-y","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T07:04:28Z","timestamp":1575961468000},"page":"375-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Effect of short-term methotrexate discontinuation on rheumatoid arthritis disease activity: post-hoc analysis of two randomized trials"],"prefix":"10.1007","volume":"39","author":[{"given":"Jin Kyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Winthrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-1208","authenticated-orcid":false,"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"issue":"9746","key":"4857_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376(9746):1094\u20131108","journal-title":"Lancet"},{"issue":"4","key":"4857_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631\u2013637","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4857_CR3","first-page":"1","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr et al (2016) 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheum 68(1):1\u201326","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4857_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landewe R, Breedveld FC et al (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73(3):492\u2013509","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4857_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrrheum.2011.171","volume":"8","author":"BM Akkara Veetil","year":"2011","unstructured":"Akkara Veetil BM, Bongartz T (2011) Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol 8(1):32\u201341","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"4857_CR6","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s10067-016-3274-1","volume":"35","author":"M Tada","year":"2016","unstructured":"Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Kinoshita T, Hidaka N, Koike T (2016) Delayed wound healing and postoperative surgical site infections in patients with rheumatoid arthritis treated with or without biological disease-modifying antirheumatic drugs. Clin Rheumatol 35(6):1475\u20131481","journal-title":"Clin Rheumatol"},{"key":"4857_CR7","doi-asserted-by":"crossref","unstructured":"Park JK, Lee MA, Lee EY et al (2017) Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis","DOI":"10.1136\/annrheumdis-2017-211128"},{"issue":"6","key":"4857_CR8","first-page":"898","volume":"77","author":"JK Park","year":"2018","unstructured":"Park JK, Lee YJ, Shin K, Ha YJ, Lee EY, Song YW, Choi Y, Winthrop KL, Lee EB (2018) Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis 77(6):898\u2013904","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4857_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"issue":"11","key":"4857_CR10","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1136\/annrheumdis-2012-202281","volume":"72","author":"A van der Maas","year":"2013","unstructured":"van der Maas A, Lie E, Christensen R, Choy E, de Man YA, van Riel P, Woodworth T, den Broeder A (2013) Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study. Ann Rheum Dis 72(11):1800\u20131805","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4857_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/ard.53.4.224","volume":"53","author":"MJ van der Veen","year":"1994","unstructured":"van der Veen MJ, van der Heide A, Kruize AA, Bijlsma JW (1994) Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 53(4):224\u2013228","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4857_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/annrheumdis-2014-206439","volume":"75","author":"J Haschka","year":"2016","unstructured":"Haschka J, Englbrecht M, Hueber AJ, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Wendler J, Schuch F, Ronneberger M, Lorenz HM, Nuesslein H, Alten R, Demary W, Henes J, Schett G, Rech J (2016) Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Ann Rheum Dis 75(1):45\u201351","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4857_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/annrheumdis-2013-204016","volume":"74","author":"Y Tanaka","year":"2015","unstructured":"Tanaka Y, Hirata S, Kubo S, Fukuyo S, Hanami K, Sawamukai N, Nakano K, Nakayamada S, Yamaoka K, Sawamura F, Saito K (2015) Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study. Ann Rheum Dis 74(2):389\u2013395","journal-title":"Ann Rheum Dis"},{"issue":"9914","key":"4857_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(13)61751-1","volume":"383","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Emery P, Fleischmann R, van Vollenhoven R, Pavelka K, Durez P, Gu\u00e9rette B, Kupper H, Redden L, Arora V, Kavanaugh A (2014) Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial. Lancet 383(9914):321\u2013332","journal-title":"Lancet"},{"issue":"7","key":"4857_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/art.1780330706","volume":"33","author":"G Nesher","year":"1990","unstructured":"Nesher G, Moore TL (1990) The in vitro effects of methotrexate on peripheral blood mononuclear cells. Modulation by methyl donors and spermidine. Arthritis Rheum 33(7):954\u2013959","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4857_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000225","volume":"2","author":"VP Bykerk","year":"2016","unstructured":"Bykerk VP, Bingham CO, Choy EH, Lin D, Alten R, Christensen R, Furst DE, Hewlett S, Leong A, March L, Woodworth T, Boire G, Haraoui B, Hitchon C, Jamal S, Keystone EC, Pope J, Tin D, Thorne JC, Bartlett SJ (2016) Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set. RMD Open 2(1):e000225","journal-title":"RMD Open"},{"issue":"4","key":"4857_CR17","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10067-014-2848-z","volume":"35","author":"T Maribo","year":"2016","unstructured":"Maribo T, de Thurah A, Stengaard-Pedersen K (2016) Patient-self assessment of flare in rheumatoid arthritis: translation and reliability of the flare instrument. Clin Rheumatol 35(4):1053\u20131058","journal-title":"Clin Rheumatol"},{"issue":"9","key":"4857_CR18","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/annrheumdis-2015-207900","volume":"75","author":"J Rech","year":"2016","unstructured":"Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, Reiser M, Cobra JF, Figueiredo C, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Schett G (2016) Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment. Ann Rheum Dis 75(9):1637\u20131644","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04857-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04857-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04857-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T21:21:27Z","timestamp":1607462487000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04857-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4857"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04857-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"30 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave written informed consent, and ethical approval was obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The funder played no role in study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all study data and takes ultimate responsibility for the decision to publish.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"EBL has acted as a consultant to Pfizer. The other authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}